Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada. Show More...
-
Website http://www.auriniapharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 7.84 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.5 -0.49 -2.74 -0.42 -0.67 -0.58 -0.66 -0.92 -0.76 -1.33 -1.34 Dividends USD Payout Ratio % * Shares Mil 3.0 3.0 4.0 6.0 29.0 32.0 35.0 77.0 85.0 93.0 99.0 Book Value Per Share * USD 1.96 3.58 -0.55 0.99 1.55 0.72 0.38 1.99 1.46 1.11 2.34 Free Cash Flow Per Share * USD -1.6 -0.52 -1.85 -0.71 -0.66 -0.52 -0.58 -0.52 -0.56 -0.58 Return on Assets % -36.92 -19.57 -105.38 -18.65 -44.09 -43.3 -51.44 -57.36 -38.2 -52.42 -53.37 Financial Leverage (Average) 1.62 2.23 1.74 1.16 1.68 1.59 1.15 1.3 1.19 1.2 Return on Equity % -65.62 -37.74 -453.7 -45.54 -57.0 -57.19 -83.33 -70.2 -46.08 -64.15 -63.54 Return on Invested Capital % -65.77 -37.41 -439.58 -44.23 -57.12 -57.35 -83.42 -71.23 -47.26 -65.17 -63.91 Interest Coverage -172.0 -62.71 -553.9 Current Ratio 4.9 3.91 0.12 0.35 11.83 4.57 5.22 21.5 18.3 27.9 21.01 Quick Ratio 4.81 2.92 0.1 0.32 11.56 4.37 5.01 21.3 17.36 27.13 20.43 Debt/Equity 0.010 0.02